.. Etudes-de-l-'urcam-limousin, 47 3.3.2, p.50

D. Résultats, 65 4.3.1. Antibiotiques et antivitamine, Tétracyclines et Roaccutane®, p.72

.. Spiramycine-et-inhibition-enzymatique and Q. Espace, 73 4.3.6. Fluoroquinolones et topiques intestinaux, p.75

C. Nr and H. Bb, Iron supplements : a common cause of drug interactions

W. Wm, C. Ts, and H. Kc, site internet de l'afssaps Thésaurus des interactions médicamenteuses http://www.afssaps.fr 17) Effect of penicillin on the renal tubular secretion of methotrexate in the monkey Cancer research, pp.1913-1917, 1984.

J. H. and P. Jb, Potentialisation of ampicillin skin reactions by allopurinol or hyperuricémia

G. A. , L. At, K. Krishnan-k, and . Cj, TROHMAN RG Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes

G. Mf, L. C. , P. G. , B. Jp, P. M. et al., Néphrotoxicité due à l'interaction pristinamycine-ciclosporine chez le transplanté rénal La Presse médicale, 1987.

C. Tf and L. Jl, Drug diffusion and bioavaibility : tétracycline metallic chelation

S. Navarro-a and D. Martinez-cabarga-m, Oral absorption of ofloxacin administered together with aluminium Antimicrob Agents Chemother, pp.2510-2512, 1994.

F. Dw, L. Kc, N. Aj, S. Ec, and L. J. , Effect of aluminium hydroxyde and calcium carbonate antiacids on the bioavaibility of ciprofloxacin

H. M. , T. Sf, V. Ls, and G. Vms, TEIXERA F Complexes of ciprofloxacin with metal ions contained in antiacid drugs

J. U. , S. F. , R. A. , S. G. , N. Kg et al., Effect of probenecid on the distribution and elimination of ciprofloxacin in humans

R. R. , N. Mm, and P. Sr, Does metronidazole interact with CYP3A substrates by inhibiting their metabolism through this metabolic pathway? Or should other mechanisms be considered?

J. Gr and H. Rz, Drug interactions involving ethanol and alcoholic beverages